17520-02-4 Usage
Steroid hormone
11-KETODEHYDROEPIANDROSTERONE is a steroid hormone that is derived from the adrenal gland.
Metabolite of Dehydroepiandrosterone (DHEA)
It is a metabolite of DHEA, which is a hormone produced by the adrenal glands.
Regulation of androgen and estrogen levels
11-KETODEHYDROEPIANDROSTERONE is involved in the regulation of androgen and estrogen levels in the body.
Anti-inflammatory properties
It has been studied for its potential anti-inflammatory properties.
Antioxidant properties
It has been studied for its potential antioxidant properties.
Neuroprotective properties
It has been studied for its potential neuroprotective properties.
Regulation of metabolism and energy balance
It plays a role in the regulation of metabolism and energy balance.
Growth and development of reproductive tissues
It plays a role in the growth and development of reproductive tissues.
Therapeutic applications
It may have potential therapeutic applications in the treatment of various conditions, such as obesity, diabetes, and neurodegenerative diseases.
More research needed
More research is needed to fully understand the effects and potential applications of 11-KETODEHYDROEPIANDROSTERONE.
Check Digit Verification of cas no
The CAS Registry Mumber 17520-02-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,7,5,2 and 0 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 17520-02:
(7*1)+(6*7)+(5*5)+(4*2)+(3*0)+(2*0)+(1*2)=84
84 % 10 = 4
So 17520-02-4 is a valid CAS Registry Number.
17520-02-4Relevant articles and documents
Synthesis of Oogoniol
Moon, Surk-Sik,Stuhmiller, Louise M.,McMorris, Trevor C.
, p. 26 - 28 (1989)
Oogoniol , a female-activating hormone of Achlya, has been synthesized from 4-androstene-3,11,17-trione.A novel step involved 1,4-addition of the magnesium cyanocuprate derivative of (S)-3-(1-methylethyl)-5-pentyl bromide to 3β-hydroxy-15β,16β-epoxy-11-oxo-(17(20)E)-pregna-5,17(20)-diene 3-tert-butyldimethylsilyl ether.Selective hydrogenation of the resulting Δ16 double bond gave only the stigmastene product with the correct stereochemistry at C15, C17, and C20.
OXYSTEROLS AND METHODS OF USE THEREOF
-
Paragraph 00247, (2018/09/25)
Compounds are provided according to Formula (I): and pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof; wherein R1, R2, R3, and R6, R11a, and R11b are as defined herein. Compounds of the present invention are contemplated useful for the prevention and treatment of a variety of conditions.